Related references
Note: Only part of the references are listed.Compounds with Therapeutic Potential against Novel Respiratory 2019 Coronavirus
Miguel Angel Martinez
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention
Zunyou Wu et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
On the use of corticosteroids for 2019-nCoV pneumonia
Lianhan Shang et al.
LANCET (2020)
Mechanisms of action of hydroxychloroquine and chloroquine: implications for rheumatology
Eva Schrezenmeier et al.
NATURE REVIEWS RHEUMATOLOGY (2020)
Clinical Characteristics of Coronavirus Disease 2019 in China
W. Guan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Weilong Shang et al.
NPJ VACCINES (2020)
Hematological findings and complications of COVID-19
Evangelos Terpos et al.
AMERICAN JOURNAL OF HEMATOLOGY (2020)
Treatment of Coronavirus Disease 2019 (COVID-19) Patients with Convalescent Plasma
Eric Salazar et al.
AMERICAN JOURNAL OF PATHOLOGY (2020)
A Rush to Judgment? Rapid Reporting and Dissemination of Results and Its Consequences Regarding the Use of Hydroxychloroquine for COVID-19
Alfred H. J. Kim et al.
ANNALS OF INTERNAL MEDICINE (2020)
COVID-19: a new challenge for human beings
Penghui Yang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Safety of Ibuprofen in Patients With COVID-19 Causal or Confounded?
Mohit Sodhi et al.
CHEST (2020)
Treatment With Convalescent Plasma for Critically Ill Patients With Severe Acute Respiratory Syndrome Coronavirus 2 Infection
Bin Zhang et al.
CHEST (2020)
In Vitro Antiviral Activity and Projection of Optimized Dosing Design of Hydroxychloroquine for the Treatment of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)
Xueting Yao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019
Juanjuan Zhao et al.
CLINICAL INFECTIOUS DISEASES (2020)
Surviving Sepsis Campaign: Guidelines on the Management of Critically Ill Adults with Coronavirus Disease 2019 (COVID-19)
Waleed Alhazzani et al.
CRITICAL CARE MEDICINE (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial
Jesus Villar et al.
LANCET RESPIRATORY MEDICINE (2020)
Cytokine release syndrome in severe COVID-19: interleukin-6 receptor antagonist tocilizumab may be the key to reduce mortality
Chi Zhang et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial
Philippe Gautret et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2020)
Lack of antiviral activity of darunavir against SARS-CoV-2
Sandra De Meyer et al.
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES (2020)
Convalescent Plasma to Treat COVID-19 Possibilities and Challenges
John D. Roback et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma
Chenguang Shen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
The convalescent sera option for containing COVID-19
Arturo Casadevall et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Deployment of convalescent plasma for the prevention and treatment of COVID-19
Evan M. Bloch et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Effective treatment of severe COVID-19 patients with tocilizumab
Xiaoling Xu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Effectiveness of convalescent plasma therapy in severe COVID-19 patients
Kai Duan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
COVID-19 illness in native and immunosuppressed states: A clinical?therapeutic staging proposal
Hasan K. Siddiqi et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2020)
Collecting and evaluating convalescent plasma for COVID-19 treatment: why and how?
Pierre Tiberghien et al.
VOX SANGUINIS (2020)
Clinical and microbiological effect of a combination of hydroxychloroquine and azithromycin in 80 COVID-19 patients with at least a six-day follow up: A pilot observational study
Philippe Gautret et al.
TRAVEL MEDICINE AND INFECTIOUS DISEASE (2020)
Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic
Elissa Driggin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Hydroxychloroquine in patients with mainly mild to moderate coronavirus disease 2019: open label, randomised controlled trial
Wei Tang et al.
BMJ-BRITISH MEDICAL JOURNAL (2020)
Non-steroidal anti-inflammatory drugs and covid-19
Paul Little
BMJ-BRITISH MEDICAL JOURNAL (2020)
Tissue plasminogen activator (tPA) treatment for COVID-19 associated acute respiratory distress syndrome (ARDS): A case series
Janice Wang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
ISTH interim guidance on recognition and management of coagulopathy in COVID-19
Jecko Thachil et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Prevalence of venous thromboembolism in patients with severe novel coronavirus pneumonia
Songping Cui et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Why tocilizumab could be an effective treatment for severe COVID-19?
Binqing Fu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2020)
Triple combination of interferon beta-1b, lopinavir-ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
Ivan Fan-Ngai Hung et al.
LANCET (2020)
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
Yeming Wang et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Cardiovascular Implications of Fatal Outcomes of Patients With Coronavirus Disease 2019 (COVID-19)
Tao Guo et al.
JAMA CARDIOLOGY (2020)
Acute asthma management during SARS-CoV2-pandemic 2020
Michael Levin et al.
WORLD ALLERGY ORGANIZATION JOURNAL (2020)
Structural basis of receptor recognition by SARS-CoV-2
Jian Shang et al.
NATURE (2020)
Virological assessment of hospitalized patients with COVID-2019
Roman Woelfel et al.
NATURE (2020)
The pandemic pipeline
John Hodgson
NATURE BIOTECHNOLOGY (2020)
The COVID-19 vaccine development landscape
Tung Thanh Le et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
Maximilian Ackermann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Remdesivir for 5 or 10 Days in Patients with Severe Covid-19
Jason D. Goldman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Trial of Lopinavir-Ritonavir in Adults Hospitalized with Severe Covid-19
B. Cao et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Developing Covid-19 Vaccines at Pandemic Speed
Nicole Lurie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19
Joshua Geleris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Compassionate Use of Remdesivir for Patients with Severe Covid-19
J. Grein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
A Retrospective Controlled Cohort Study of the Impact of Glucocorticoid Treatment in SARS-CoV-2 Infection Mortality
Ana Fernandez-Cruz et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy
Giacomo Grasselli et al.
JAMA INTERNAL MEDICINE (2020)
Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study
Valentina Giudice et al.
FRONTIERS IN PHARMACOLOGY (2020)
Identification of pathophysiological patterns for triage and respiratory support in COVID-19
Luigi Camporota et al.
LANCET RESPIRATORY MEDICINE (2020)
Monoclonal Antibodies for Prevention and Treatment of COVID-19
Mary Marovich et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Early safety indicators of COVID-19 convalescent plasma in 5000 patients
Michael J. Joyner et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
No evidence of rapid antiviral clearance or clinical benefit with the combination of hydroxychloroquine and azithromycin in patients with severe COVID-19 infection
J. M. Molina et al.
MEDECINE ET MALADIES INFECTIEUSES (2020)
A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19
David R. Boulware et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Efficacy and Safety of Lopinavir/Ritonavir or Arbidol in Adult Patients with Mild/Moderate COVID-19: An Exploratory Randomized Controlled Trial
Yueping Li et al.
MED (2020)
The Emerging Role of Convalescent Plasma in the Treatment of COVID-19
Theodora Psaltopoulou et al.
HEMASPHERE (2020)
Coronary Risks Associated with Diclofenac and Other NSAIDs: An Update
Nicholas Moore
DRUG SAFETY (2020)
Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia
Ling Lin et al.
EMERGING MICROBES & INFECTIONS (2020)
Investigation of the Quantity of Exhaled Aerosols Released into the Environment during Nebulisation
James A. McGrath et al.
PHARMACEUTICS (2019)
Risks Related to the Use of Non-Steroidal Anti-Inflammatory Drugs in Community-Acquired Pneumonia in Adult and Pediatric Patients
Guillaume Voiriot et al.
JOURNAL OF CLINICAL MEDICINE (2019)
The effect of high-flow nasal cannula in reducing the mortality and the rate of endotracheal intubation when used before mechanical ventilation compared with conventional oxygen therapy and noninvasive positive pressure ventilation. A systematic review and meta-analysis
Yue-Nan Ni et al.
AMERICAN JOURNAL OF EMERGENCY MEDICINE (2018)
Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome
Yaseen M. Arabi et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2018)
Hydroxychloroquine: An old drug with new relevance
Eugen Alexander Shippey et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2018)
Estimating the cost of vaccine development against epidemic infectious diseases: a cost minimisation study
Dimitrios Gouglas et al.
LANCET GLOBAL HEALTH (2018)
Acute Respiratory Infection and Use of Nonsteroidal Anti-Inflammatory Drugs on Risk of Acute Myocardial Infarction: A Nationwide Case-Crossover Study
Yao-Chun Wen et al.
JOURNAL OF INFECTIOUS DISEASES (2017)
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Timothy P. Sheahan et al.
SCIENCE TRANSLATIONAL MEDICINE (2017)
Inhaled nitric oxide for acute respiratory distress syndrome (ARDS) in children and adults
Fabienne Gebistorf et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2016)
High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure
Jean-Pierre Frat et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
Use of convalescent plasma therapy in SARS patients in Hong Kong
Y Cheng et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2005)
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
CM Chu et al.
THORAX (2004)
Effects of early corticosteroid treatment on plasma SARS-associated Coronavirus RNA concentrations in adult patients
N Lee et al.
JOURNAL OF CLINICAL VIROLOGY (2004)
Antibody-mediated regulation of cellular immunity and the inflammatory response
A Casadevall et al.
TRENDS IN IMMUNOLOGY (2003)
Share Paper
